The androgen receptor -- a protein ignition switch for prostate cancer cell growth and division -- is a master of adaptability. When drug therapy deprives the receptor of androgen hormones, thereby halting cell proliferation, the receptor manages to find an alternate growth route. A new study demonstrates how.
Full article >>
Thursday, July 30, 2009
Reprogrammed Role For The Androgen Receptor
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment